{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-017218","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2025-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.887604+00:00","generated_at":"2026-05-27T06:17:52.781356+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ResMed reports Q2 FY2025 revenue up 10% to $1.28B; non-GAAP EPS $2.43, up 29%","bullets":["Revenue $1.28B (+10% YoY); gross margin 58.6% (+300 bps) on manufacturing efficiencies.","Non-GAAP diluted EPS $2.43 (+29%); operating income $417M (+52% vs $275M, prior year had $64M restructuring).","Operating cash flow $309M; paid $78M dividends and repurchased $75M shares during quarter.","Board declared $0.53 quarterly dividend; record Feb 13, 2025, payable Mar 20, 2025.","Residential Care Software revenue up 8% constant currency; U.S./Canada/Latin America revenue up 12%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-017218","json":"https://secwatch.observer/filing/0001193125-25-017218.json","markdown":"https://secwatch.observer/filing/0001193125-25-017218.md","text":"https://secwatch.observer/filing/0001193125-25-017218.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312525017218/0001193125-25-017218-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312525017218/d888970d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T06:17:52.781356+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}